Quipt Home Medical (NASDAQ:QIPT) Given New $8.00 Price Target at Canaccord Genuity Group

Quipt Home Medical (NASDAQ:QIPTFree Report) had its price target lowered by Canaccord Genuity Group from $9.00 to $8.00 in a report issued on Friday, Benzinga reports. The firm currently has a buy rating on the stock.

Separately, Raymond James lowered Quipt Home Medical from a market perform rating to an underperform rating and reduced their target price for the stock from $10.00 to $2.50 in a report on Friday.

View Our Latest Report on Quipt Home Medical

Quipt Home Medical Trading Up 2.5 %

Shares of NASDAQ:QIPT opened at $3.23 on Friday. Quipt Home Medical has a 1 year low of $2.96 and a 1 year high of $6.01. The firm has a fifty day moving average price of $3.96 and a 200 day moving average price of $4.44. The company has a current ratio of 1.13, a quick ratio of 0.79 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $137.50 million, a PE ratio of -32.30 and a beta of 0.68.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Price T Rowe Associates Inc. MD grew its stake in shares of Quipt Home Medical by 25.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,829 shares of the company’s stock worth $57,000 after purchasing an additional 2,640 shares during the period. Perritt Capital Management Inc. raised its stake in shares of Quipt Home Medical by 1.7% in the 3rd quarter. Perritt Capital Management Inc. now owns 215,500 shares of the company’s stock valued at $1,097,000 after purchasing an additional 3,698 shares during the period. Tower Research Capital LLC TRC lifted its stake in Quipt Home Medical by 141.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,755 shares of the company’s stock valued at $34,000 after acquiring an additional 3,956 shares in the last quarter. Bridge City Capital LLC lifted its position in shares of Quipt Home Medical by 17.9% in the first quarter. Bridge City Capital LLC now owns 47,721 shares of the company’s stock worth $209,000 after purchasing an additional 7,244 shares in the last quarter. Finally, Sonora Investment Management Group LLC bought a new stake in Quipt Home Medical during the 3rd quarter worth about $51,000. 42.85% of the stock is owned by institutional investors and hedge funds.

Quipt Home Medical Company Profile

(Get Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

Read More

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.